The weekly ESA dose corrected for epoetin/darbepoetin (× 250) was significantly higher 5154 (6077) U in HD patients in Portugal as compared to those in Poland (3133 (3068) U, p <  0.001). This evidence concerns the gene EPO and Huntington disease.